Molecular docking studies of natural and synthetic compounds against human secretory PLA2 in therapeutic intervention of inflammatory diseases and analysis of their pharmacokinetic properties
Online Publishing @ NISCAIR
View Archive InfoField | Value | |
Authentication Code |
dc |
|
Title Statement |
Molecular docking studies of natural and synthetic compounds against human secretory PLA2 in therapeutic intervention of inflammatory diseases and analysis of their pharmacokinetic properties |
|
Added Entry - Uncontrolled Name |
Choudhury, Manisha Sharma, Dolly Das, Manas Dutta, Karabi |
|
Uncontrolled Index Term |
ADMET; AutoDock; Inflammation; sPLA2 inhibitor |
|
Summary, etc. |
Literature survey reveals that there are several natural and synthetic anti-inflammatory compounds reported till date. As a therapeutic drug target, PLA2 inhibition is preferred over other anti-inflammatory drug targets. The pro-inflammatory effects of group X sPLA2 are acquired from multiple pathways. This study aims to identify the best anti-inflammatory compound among 22 compounds reported in literature using in silico approach. The compound ligands are subjected to docking against the target protein human sPLA2 [PDB ID: 5G3M] at the active site using AutoDock 4.2.6. Based on the Δ binding free energy and hydrogen bonding interactions, it was observed that ten compounds fit at the active site. Out of these, compound 1 (14-deoxyandrographolide) was selected as the best compound. Absorption, distribution, metabolism, and excretion (ADME) properties of the ligands are analyzed using pkCSM software available online. Compound 1 exhibited the best conformational fit when compared to the co-crystal inhibitor 4-Benzylbenzamide. |
|
Publication, Distribution, Etc. |
Indian Journal of Biochemistry and Biophysics (IJBB) 2022-02-03 00:00:00 |
|
Electronic Location and Access |
application/pdf http://op.niscair.res.in/index.php/IJBB/article/view/27977 |
|
Data Source Entry |
Indian Journal of Biochemistry and Biophysics (IJBB); IJBB Vol. 59 (1) [January 2022] |
|
Language Note |
en |
|